Life Sciences

This research service focuses on antiviral/antiretroviral therapeutics for the treatment of HIV/AIDS. A product and pipeline assessment is provided for marketed and investigational products and combination regimens for the treatment of HIV infection. Segmentation by drug class is provided along with additional supporting information such as clinica...

This issue of Vital Signs, released on July 1, 2014, discusses the FDA approval of Biogens Eloctate, Qiagens acquisition of Primera Dx, Roches acquisition of Genia Technologies, Cues at-home connected lab test, and the Credihealth Teen Clinic.

This study provides data for the Western European in vitro diagnostics (IVD) market. Haematology, haemostasis, urinalysis, microbiology, clinical chemistry, point-of-care testing, molecular diagnostics, tissue diagnostics, self-monitoring blood glucose and immunochemistry are the segments within this market. Market revenues have been included in th...

This market insight provides market data for the urinalysis market in Western Europe. Market segments include instruments and reagents. Instruments included are sediment, automated dipstick, and integrated analysers. Market revenues for instruments and reagents have been discussed for all of Western Europe—the United Kingdom, France, Germany, It...

The total market, as defined by this study, includes next-generation sequencing instruments and reagents. Instruments include those that use newer technology than traditional capillary electrophoresis (CE) sequencing, such as sequencing-by-synthesis, sequencing-by-ligation, single-molecule sequencing, and semiconductor sequencing. This research ser...

This research service focuses on antiviral/antiretroviral therapeutics for the treatment of HIV/AIDS. A product and pipeline assessment is provided for marketed and investigational products and combination regimens for the treatment of HIV infection. Segmentation by drug class is provided along with additional supporting information such as clinica...

This issue of Vital Signs, released on June 2, 2014, discusses the latest strategy surrounding mega deals in the pharma/biotech industry, Eurofins agreement to acquire ViroCor-IBT Laboratories, Qiagens acquisition of BIOBASE, and the FDAs latest announcement on regulatory requirements for biosimilars.

This market insight provides market data for the Western European hemostasis diagnostics market. Market segments include instruments and reagents. Market revenues and installed base-units for total Western Europe, the United Kingdom, France, Germany, Italy, Spain, Nordic countries, and Benelux have been included in this deliverable. Further analysi...

Biomarkers will certainly change the way healthcare is provided. They are being increasingly used in early drug development and for clinical use as well, boosting their demand. The penetration of biomarkers in various therapeutic applications, the impact of market trends and dynamics are analysed in this study. This research service offers market o...